[{"NetIncomeLossConverted_3_Q3_USD":-18467000.0,"NetIncomeLossConverted_1_Q3_USD":-4447000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":12107000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":12066000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":15507000.0,"EarningsPerShareDiluted_1_Q3_USD":-0.37,"EarningsPerShareDiluted_3_Q3_USD":-1.53,"StockholdersEquity_0_Q3_USD":191403000.0,"RevenuesConverted_1_Q3_USD":52061000.0,"RevenuesConverted_3_Q3_USD":155207000.0,"Assets_0_Q3_USD":470454000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":12107000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":12066000.0,"EarningsPerShareBasic_1_Q3_USD":-0.37,"EarningsPerShareBasic_3_Q3_USD":-1.53,"Ticker":"ANIP","CIK":"1023024","name":"ANI PHARMACEUTICALS INC","OfficialName":"ANI Pharmaceuticals Inc.","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"569805985.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20211101"}]